Erratum: Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma (Blood ( 2017) 130, 5 (2709-2717) DOI: 10.1182/blood-2017-05-780049)

In Table 3 on page 2716 of the 21 December 2017 issue, the second and third column headings are reversed. The second column heading should read “SCT (n ₌ 8),” and the third column heading should read “No SCT (n ₌ 8).” The corrected Table 3 is shown below. (Figure presented). In lines 9 and 10 of the left column on page 2714, “7 patients (88%)” should read “4 patients (50%).” In the next-to-last line of the right column on page 2715, “the majority (7 of 8)” should read “4.” In lines 5 and 6 of the left column on page 2716, “patients who received SCT” should read “patients who did not receive SCT.” The errors have been corrected in the online version of the article.